Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nautilus Biotechnology (NAUT) Interest & Investment Income (2021 - 2026)

Nautilus Biotechnology has reported Interest & Investment Income over the past 6 years, most recently at $1.4 million for Q1 2026.

  • Quarterly results put Interest & Investment Income at $1.4 million for Q1 2026, down 35.37% from a year ago — trailing twelve months through Mar 2026 was $7.1 million (down 30.15% YoY), and the annual figure for FY2025 was $7.9 million, down 27.01%.
  • Interest & Investment Income reached $1.4 million in Q1 2026 per NAUT's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.2 million in Q2 2023 and bottomed at $264000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 5 years was $2.4 million (2024), compared with a mean of $2.3 million.
  • The largest annual shift saw Interest & Investment Income skyrocketed 1693.17% in 2022 before it crashed 35.37% in 2026.
  • Over 5 years, Interest & Investment Income stood at $2.9 million in 2022, then grew by 5.06% to $3.0 million in 2023, then dropped by 19.85% to $2.4 million in 2024, then plummeted by 31.96% to $1.7 million in 2025, then decreased by 12.82% to $1.4 million in 2026.
  • Business Quant data shows Interest & Investment Income for NAUT at $1.4 million in Q1 2026, $1.7 million in Q4 2025, and $1.9 million in Q3 2025.